2024年10月7日 · Palbociclib is used to treat adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer. It should always be used in combination with another …

Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective …

Palbociclib is a medication that stops cancer cells from growing. It treats breast cancer. This type of cancer occurs when cells in your breast grow and divide in an uncontrolled way, creating a …

Medscape - Breast cancer dosing for Ibrance (palbociclib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

Palbociclib (Ibrance®) is used to treat breast cancer that is oestrogen receptor positive and HER2 negative. It may be used if the cancer has spread: to the tissues and lymph nodes close to the …

Palbociclib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of …

2024年11月20日 · Ibrance (palbociclib) is an expensive medicine used to treat breast cancer, but most people do not pay the full price for this drug. Your insurance, the manufacturer of …

Palbociclib is used to treat hormone receptor (HR)-positive, HER-2 negative advanced or metastatic (cancer that has spread) breast cancer. This medicine is used in combination with …

Palbociclib works by blocking the activity of proteins called CDK4 and CDK6 that control how fast cells grow. Blocking these proteins may slow or stop the growth of cancer cells. Palbociclib is …

2022年12月12日 · What is this drug used for? It is used to treat breast cancer. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this drug; or …